Case Report
Copyright ©The Author(s) 2025.
World J Clin Oncol. Feb 24, 2025; 16(2): 95642
Published online Feb 24, 2025. doi: 10.5306/wjco.v16.i2.95642
Figure 3
Figure 3 Percentage of peripheral blood lymphocytes during PRaG treatment. The percentage of CD4+T cells and CD8+T cell subsets increased to varying degrees during PRaG treatment.